Abstract: The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.
Type:
Grant
Filed:
June 28, 2016
Date of Patent:
December 11, 2018
Assignee:
Ixchelsis Limited
Inventors:
Alan Daniel Brown, Andrew Antony Calabrese, David Ellis
Abstract: The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.
Type:
Grant
Filed:
April 20, 2015
Date of Patent:
July 19, 2016
Assignee:
Ixchelsis Limited
Inventors:
Alan Daniel Brown, Andrew Antony Calabrese, David Ellis
Abstract: The present invention relates to substituted triazoles of formula (I), uses thereof, processes for the preparation thereof and compositions containing said compounds. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction.
Type:
Grant
Filed:
May 23, 2012
Date of Patent:
May 5, 2015
Assignee:
Ixchelsis Limited
Inventors:
Alan Daniel Brown, Andrew Antony Calabrese, David Ellis
Abstract: A composition comprising a selective oxytocin antagonist for use in the treatment and/or prevention of a male ejaculatory disorder; which selective oxytocin antagonist is optionally admixed with a pharmaceutically acceptable carrier, diluent or excipient.
Type:
Application
Filed:
September 24, 2014
Publication date:
March 12, 2015
Applicant:
Ixchelsis Limited
Inventors:
Alasdair Mark Naylor, Rachel Jane Russell, Stephen Derek Albert Street, Kim-Wah Tang, Pieter Hadewijn Van Der Graaf, Christopher Peter Wayman